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comparative analysis of cardiac 
mechano-energetics in isolated 
hearts supported by pulsatile or 
rotary blood pumps
Marcus Granegger  1,2,3*, Young choi1,2, Benedikt Locher1,2, Philipp Aigner4,5, 
emanuel J. Hubmann1,2, Frithjof Lemme1,2, Nikola cesarovic6, Michael Hübler1,2 & 
Martin Schweiger1,2
The previously more frequently implanted pulsatile blood pumps (PBPs) showed higher recovery rates 
than the currently preferred rotary blood pumps (RBPs), with unclear causality. The aim of this study 
was to comparatively assess the capability of PBPs and RPBs to unload the left ventricle and maintain 
cardiac energetics as a possible implication for recovery. An RBP and a heartbeat synchronized PBP 
were alternately connected to isolated porcine hearts. Rotational speed of RBPs was set to different 
support levels. For PBP support, the start of ejection was phased to different points during the cardiac 
cycle, prescribed as percentage delays from 0% to 90%. Cardiac efficiency, quantified by the ratio 
of external work over myocardial oxygen consumption, was determined. For RBP support, higher 
degrees of RBP support correlated with lower left atrial pressures (LAP) and lower cardiac efficiency 
(r = 0.91 ± 0.12). In contrast, depending on the phase delay of a PBP, LAP and cardiac efficiency 
exhibited a sinusoidal relationship with the LAP minimum at 90% and efficiency maximum at 60%. 
Phasing of a PBP offers the possibility to maintain a high cardiac efficiency and simultaneously unload 
the ventricle. These results warrant future studies investigating whether optimized cardiac energetics 
promotes functional recovery with LVAD therapy.
Mechanical circulatory support (MCS) has progressed from large extracorporeal pulsatile flow devices to smaller 
continuous flow rotary blood pumps (RBPs). The formerly more frequently used pulsatile blood pumps (PBPs) 
were gradually replaced with newly developed RBPs due to improved survival rates, smaller device sizes, and 
higher reliability1. In the last 10 years, the global number of implanted RBPs substantially exceeded the number 
of implanted PBPs, currently accounting for 97% of total implants2,3. Although the survival rates of MCS patients 
improved significantly during this period, the cardiac recovery rates remained sparse4. Krabatsch et al. observed 
an almost threefold higher chance of cardiac recovery in patients treated with PBPs compared to RBPs5. What 
causes these differences in cardiac recovery rates between RBPs and PBPs remains unclear.
Functional cardiac recovery for end-stage heart failure during left ventricular assist device (LVAD) sup-
port with subsequent device explantation constitutes a curative treatment option for the dysfunctional heart6–8. 
Therefore, the process of reversing the pathological morphology of failing hearts and how functional remodeling 
is induced, is of great interest. The adverse remodeling of the failing heart is primarily triggered by left ventricular 
pressure- or volume-overload9,10. This leads to several unfavorable intra- and extracellular changes in the myocar-
dium such as cardiac hypertrophy, disturbed calcium homeostasis, and fibrosis11.
Recent studies suggest that ventricular unloading with MCS is the main stimulus that stops myocardial 
remodeling and reverses the negative changes to some extent10,12–14. Hence, the pursuit to delineate the optimal 
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conditions for reverse remodeling and cardiac recovery with MCS has become an ongoing research topic and 
major focus in the scientific community8,9. Presently, it is debated whether prolonged MCS support with RBPs 
may not only lead to beneficial reverse remodeling but in parallel induce unfavorable myocardial atrophy15,16. 
The theory behind possible atrophy being that decreased myocardial energy demand due to excessive unloading 
causes myocardial hibernation and suppression of cellular repair17. This decline toward cardiac atrophy could 
possibly be prevented by providing a balanced degree of ventricular unloading that adequately unloads the LV 
without inducing the negative cascade toward atrophy.
A healthy cardiovascular system adapts the loading conditions and the ventricular properties to operate at a 
state of maximum cardiac efficiency, defined as the ratio between external ventricular work (EW) and myocar-
dial oxygen consumption18. In the case of heart failure, the loading conditions with a highly elevated ventricular 
preload lead to a ventricle that no longer operates at the state of highest cardiac efficiency in order to provide 
sufficient cardiac output (CO) and systemic pressure19. These effects may be amplified by the fact that not only 
the boundary conditions are affected by chronic heart failure but also the ventricles’ peak efficiency is shifted to 
even lower preloads and afterloads20. The adversely altered loading situations cause a diminished ratio of useful 
mechanical work and consumed energy in the failing heart, which indicates that cardiac energetics are shifted to 
less efficient conditions.
To promote cardiac recovery, it may be beneficial to reestablish the operating condition of a healthy ventricle. 
This may be achieved by reducing the volume overload while simultaneously maintaining a high cardiac effi-
ciency21. Whereas it has been previously shown how cardiac mechanics and hemodynamics are affected by RBPs 
and PBPs22,23, cardiac efficiency has not yet been investigated in a realistic setting. Therefore, the aim of this study 
was to comparatively assess cardiac hemodynamics, mechanics, and energetics between left ventricles supported 
by RBPs and PBPs in an ex-vivo isolated beating heart. We hypothesized that phasing of a PBP offers an additional 
degree of freedom to alter cardiac efficiency.
Results
With the RBP implanted, in six isolated porcine hearts at least three speed settings were recorded with stable car-
diac output, aortic pressure (AoP), and heart rate (HR, acceptance criteria ±10%) throughout the speed changes 
(Table 1). With the PBP implanted, in three experiments at least one complete cycle from 0% to 90% phase delay 
was successfully recorded with stable cardiac output, aortic pressure, and heart rate throughout each phase sweep 
(Table 1).
Hemodynamics with the RBP systems. Increasing pump speed of an RBP at constant cardiac output and 
arterial pressure lowered the ventricular preload, while simultaneously shifting the pressure – volume (PV) loop 
to lower volumes and decreasing EW (Fig. 1). Mean pump flow increased until the ventricle was fully supported 
(instantaneous left ventricular pressure (LVP) lower than the aortic pressure) and remained constant afterwards 
despite increasing pump speeds.
The assistance ratio, defined as the ratio of mean pump flow in each support condition over the constant car-
diac output, increased with increasing pump speeds (Fig. 2) indicating the transition of partial to full support at 
higher speed settings. For the purpose of statistical analysis, the speed setting was categorized into five ranges: (1) 
<2200 rpm, (2) 2200–2400 rpm, (3) 2400–2600 rpm, (4) 2600–2800 rpm, (5) >2800 rpm.
Figure 3 (left) summarizes the relevant hemodynamic parameters of the six RBP experiments normalized by 
the maximum value for each experiment to compensate for inter-experimental variability. It can be observed that 
the median left atrial pressure (LAP), EW, and cardiac efficiency decreased by approx. 50% when comparing the 
lowest and highest speed setting; Median oxygen consumption decreased by approx. 20%. Peak LVP decreased 
once the aortic valve is closed during the entire heart cycle (full support at speed settings 4 and 5).
In each of the six experiments, cardiac efficiency and LAP correlated strongly (r = 0.91 ± 0.12). Linear regres-
sion analysis revealed a median slope [IQR] of 0.28 [0.91] %/mmHg and a median intercept [IQR] of 2.98 [7.52] 
%. Figure 4 (left) depicts the effect of increasing pump speed on LAP and cardiac efficiency for each of the 6 
experiments.
Hemodynamics with the PBP system. At a constant cardiac output, the lowest preload occurred during 
a phase delay of 75 to 90% (Fig. 5) Systolic LVP was highest at a phase delay of 90% since the ventricle ejected 
immediately after the pump and therefore against the systolic pressure generated by the pump ejection. It can be 
observed that the shape of the PV loops as well as the EW are strongly affected by the phase delay of ejection with 
the highest EW occurring at a phase delay of 60 to 75%.
The assistance ratio indicates a tendency towards full support conditions from 30 to 60% phase delay (Fig. 2).
Figure 3 summarizes the relevant hemodynamic parameters of three PBP experiments normalized by the 
maximum value for each experiment (right) to compensate for inter-experimental differences. It can be observed 
Heart Rate (bpm) Cardiac Output (L/min) Aortic Pressure (mmHg)
RBP support (n = 6) Median 79Range 50–103
Median 4.4
Range 3.3–5.0
Median 74
Range 58–81
PBP support (n = 3) Median 88Range 73–94
Median 4.1
Range 3.4–4.7
Median 67
Range 51–71
Table 1. Median and range of baseline hemodynamic parameters of the experiments with RBP and PBP 
support, n indicates the number of experiments. RBP – rotary blood pump; PBP – pulsatile blood pump.
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that the median LAP, EW, and cardiac efficiency are strongly affected by the phasing of the pulsatile pump in a 
sinusoidal manner – LAP was highest at the 30 to 45% delay conditions, whereas peak LVP, EW and cardiac effi-
ciency peaked at phase delays of 60 to 75%; Oxygen consumption was highest around a 60% phase delay.
Three representative plots showing the relationships of phase delay of a PBP system with efficiency and preload 
are presented in Fig. 4. It was observed that preload and cardiac efficiency are not correlated (r = 0.10 ± 0.37) and 
are influenced in a non-linear manner: depending on the phase delay, different cardiac efficiencies were observed 
independent of preload.
Discussion
In this study, a large animal isolated beating heart setup allowed the direct comparison of hemodynamics, cardiac 
mechanics, and energetics between LVAD support with a RBP and a PBP under well controlled hemodynamic 
conditions. In contrast to acute animal models, autoregulatory mechanisms such as the baroreflex and the influ-
ence of altered conditions in the venous system, right heart, and pulmonary circulation are completely decoupled. 
Further, the experimental setup facilitates easy application of advanced measurement systems such as a left ven-
tricular PV loop catheter, various flow and pressure measurements, and continuous monitoring of arterial and 
venous oxygen content.
Figure 1. Typical time courses of pressure and flows at three different pumps speeds (upper and mid panel) at a 
cardiac output of 3.4 L/min. In the lower panel the respective PV loops are depicted.
Figure 2. Box plots of assistance ratios recorded during RBP and PBP support. The sample size of each 
measurement is noted below each of the boxes.
4Scientific RepoRtS |         (2019) 9:20058  | https://doi.org/10.1038/s41598-019-56344-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
The ideal RBP speed setting to potentially promote myocardial recovery is a matter of debate. It is well known 
that increased RBP speed increases pump flow and reduces ventricular preload, as well as reduces EW and myo-
cardial oxygen consumption23–25. While it is possible to fully assist the failing left ventricle with an RBP by deliv-
ering the entire cardiac output through the pump, it is clinically recognized that at least intermittent aortic valve 
opening is preferable for various reasons (i.e. thrombus formation, aortic valve function)26. Fully assisting the 
ventricle may also detrimentally affect myocardial reverse remodeling and recovery: A pump in full support 
unloads the heart but at the potential consequence of leading to atrophy of the myocardium due to excessive 
reduction in wall stresses. On the other hand, partial support may not reduce volume and pressure sufficiently 
to reverse myocardial remodeling, especially in patients with severely weak heart function. Although the ideal 
unloading strategy for myocardial recovery is unknown, it is commonly believed that training of the ventricle by 
adapting pump speed and varying the load on the ventricle may be beneficial to promote reverse remodeling and 
recovery21,27.
In this study we replicated the entire range of RBP support in isolated hearts from aggressive full to partial 
support conditions. We showed that with increasing RBP speed, EW is disproportionally more reduced compared 
to the total myocardial energy consumption, leading to a diminished cardiac efficiency in conditions of large 
degrees of unloading. This may be explained by the fact that during full support, the ventricular pre- and afterload 
decrease in tandem, leading to adverse boundary conditions for the ventricle. Based on these findings, an RBP 
driven at a constant speed cannot achieve a condition of a high cardiac efficiency with a simultaneously low LAP 
similar to that of a healthy left ventricle.
PBPs can be driven in two modes—asynchronously or synchronously to the native cardiac cycle. For asyn-
chronously driven PBPs, the rate and the ejection volume can be prescribed to adapt the level of ventricular sup-
port. It was suggested that reloading strategies with reduction of these parameters could facilitate weaning from 
the device28; However, each heart beat supported by an asynchronously driven PBP can vary widely: dependent 
Figure 3. Box plots of hemodynamic parameters normalized by the maximum value of each experiment for the 
RBP and PBP. The number of included measurements in each of the box is presented in the upper panels.
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on the native heart rate and prescribed pump beat rate, the ventricle is loaded and/or ejects into the pump differ-
ently. Preload, afterload, EW, myocardial oxygen consumption, and therefore also cardiac efficiency is different 
for each beat. A synchronously driven PBP enables a nearly consistent mode of support and is adjusted by phasing 
of the ejection and filling of the pump—for this experiment, prescribed as the phase delay. It has previously been 
shown in comprehensive studies22 that the pump phasing has an important influence on the unloading properties 
of the left ventricle, however, the effect on myocardial oxygen consumption and cardiac efficiency had not yet 
been investigated.
In contrast to RBPs, PBPs decouple unloading and ejection by the storage of blood in the pump chamber, 
thereby, tailoring the extent of preload reduction and afterload adaptation independent from each other. This 
way, cardiac efficiency can be augmented by adjusting pump ejection and filling phases within the cardiac cycle. 
We showed that cardiac efficiency can be adapted by adjusting the phase delay of ejection: a ventricle supported 
by an adjustably phased PBP demonstrated the capacity to operate at a low preload with highest efficiencies at a 
phase delay of 60 to 75%. Thereby, a potential technique is granted for modifying parameters that may form ideal 
boundary conditions for promoting reverse cardiac remodeling and eventually cardiac recovery.
Further steps to corroborate the presented support strategy for reverse cardiac remodeling and recovery 
include similar experiments in chronic animal models with induced heart failure. This would be critical to prove 
the hypothesis that pulsatile LVAD support maintaining cardiac efficiency and a physiologic preload is beneficial 
for long-term reverse remodelling and recovery.
Figure 4. Relationship between LAP, pump speed, and cardiac efficiency for 6 experiments (visualized by 
different symbols) with an RBP. The linear regression relationship for each of the 6 experiments as well as 
the median linear fit is indicated (left); Relationship between LAP, cardiac efficiency, and phase delay for 3 
experiments with a PBP (right). Starting in the left lower corner of each panel, the relationships develop in a 
counter-clock wise manner with increasing phase delay.
Figure 5. Typical time courses of pressure and flow at different phase delays (upper and mid panel) at a cardiac 
output of 3.4 L/min. In the lower panel the respective PV loops are depicted.
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Limitations. In this study, the contribution of the right ventricle to the myocardial oxygen consumption 
was kept low since the ventricle ejected only the coronary flow against a low pressure of 10 to 20 mmHg. Further, 
during each experiment the right ventricular output was almost constant, therefore, the relative changes in 
mechano-energetic parameters can be attributed to the altered loading conditions of the left ventricle. Further, 
healthy isolated porcine hearts were utilized which comes with several limitations: the ventricular geometry does 
not reflect the one of typically dilated cardiomyopathies in terms of ventricular size and wall thickness. In these 
experiments, although a deteriorating cardiac function over time was observed, we did not reach conditions of 
decompensated heart failure.
The number of experiments with the synchronized PBP was low, however, the repeatability of experiments was 
excellent (Fig. 4), which supports the validity of the presented findings.
Materials and Methods
the isolated heart setup. Porcine hearts of 8 landrace pigs (80–106 kg) were explanted similar to the pro-
tocol described previously25. For the explantation, a median sternotomy was performed in anesthetized pigs and 
the aorta was cannulated with a cardioplegic needle. Animals were exsanguinated via an aortic cannula placed in 
the iliac artery. As soon as 2 liters of blood were collected, the ascending aorta was clamped distal to the cardiople-
gic needle and 1 liter of cardioplegic solution (Custodiol, Dr. Franz Köhler Chemie GmbH, Bensheim, Germany) 
was applied. Simultaneously, the heart was cooled with a slurry ice solution until cardiac activity ceased.
The heart was excised and prepared for the connection to the isolated heart apparatus (Fig. 6). The right 
atrium was closed and a single pulmonary vein from the left atrium was left open for connection of the heart to 
the preload reservoir. The left ventricular apex was cored and a HVAD sewing ring (Medtronic, Minneapolis, MN, 
USA) was attached to the ventricle to allow pump implantation.
The isolated heart apparatus features three connections from the heart to the circuit (Fig. 6). First, the aorta 
was connected to an air-trapped reservoir mimicking the arterial Windkessel29 system. Second, the pulmonary 
artery was connected to an open venous reservoir so that coronary flow was ejected against a low pressure of 10 
to 20 mmHg. Third, the left atrium was cannulated and connected to a pressure-controlled air-trapped reservoir 
which constitutes the preload adjustment system.
To resuscitate the isolated hearts, the Langendorff perfusion technique was used, where the pressure in the 
arterial reservoir was gradually increased to 70 mmHg. Thereby, the coronary arteries were perfused with oxygen-
ated blood at a temperature of 37 °C. If necessary, the hearts were defibrillated to achieve a stable sinus rhythm. 
Once the heart stabilized, the setup was switched to the working mode, during which the heart pumps blood 
from the preload reservoir towards the arterial one making the left heart circulation similar to normal physi-
ology (Fig. 6). All experiments were performed in accordance with the relevant guidelines and regulations and 
approved by the Ethics Committee (approval no. 219/16) of the Canton of Zurich.
To investigate the differences of RBP and PBP support, we alternately supported each ventricle with the Excor 
system (BerlinHeart GmbH, Berlin, Germany) or the Medtronic HVAD system. In the first 4 experiments, the 
Excor was driven with the BerlinHeart ExcorActive driving unit. However, this driving unit does not permit 
synchronized triggering to the native heart rate. Therefore, we developed our own pneumatic actuation system 
and an appropriate triggering and control algorithm which was used in the last 4 experiments. The developed 
pneumatic system consisted of an air compressor (KNF Neuberger PM21308-023.1.2, Freiburg, Germany) to 
Figure 6. Schematic diagram and picture of the isolated heart setup in Working Mode (adapted from 
Granegger et al.25) with the pumps implanted.
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provide both positive and vacuum pressure, two air tanks connected to relief valves (Niezgodka Gmbh 91-2508-4 
and 1831, Hamburg, Germany), and a 5/3-way solenoid control valve (Festo MPYe-5-1/4-010-B, Esslingen am 
Neckar, Germany). Filling and ejection were controlled by an embedded control system developed in Simulink 
(Mathworks, Natick, MA, USA) and loaded onto a dSPACE MicroLabBox (dSPACE GmbH, Paderborn, 
Germany).
Zero-crossing detection was used to attain an accurate measurement of the sinus heartbeat duration. Using 
the left ventricular pressure as an input, its moving mean was subtracted from itself to generate a zero-crossing 
pulse signal: rising zeros occurred during ventricular systole and falling zeros during diastole. Beat duration 
was calculated as the duration between two rising zero crossings. The applied delays signaling for pump ejection 
phasing were a percentage of the beat duration and triggered from the rising zero cross point. Pump filling was 
then triggered at 35% of beat duration after pump ejection. Pump filling and pump ejection was passed as a state 
signal to a PID controller that actuated the solenoid control valves to flip the PBP from ejection and filling states. 
The measured pneumatic driving pressure was the process variable signal returned to the PID controller.
Measurement protocol. Two conditions were investigated at a constant cardiac output, adjusted by the 
roller pump of the isolated heart setup (Fig. 6):
 1. With the RBP connected, the pump speed was gradually increased to raise ventricular unloading
 2. With a synchronized PBP connected, the pump was phased to eject at a delay of 0, 15, 30, 45, 60, 75, and 
90%.
As soon as all parameters stabilized and at least 30 seconds after the change in speed/phase delay, the following 
variables were recorded for all test conditions:
 1. Volume flows: aortic, pump, and coronary flow (SONOFLOW CO.55, Sonotec, Halle, Germany)
 2. Pressures:
a. aortic, left atrial, and pulmonary artery pressure (PAP) (APT300, Harvard Apparatus, Hollisten, MA, 
USA)
b. left ventricular pressure (Ventri-Cath 507 PV Loop Catheter/MPVS Ultra PV Unit, ADInstruments, 
Sydney, Australia)
c. pneumatic driving pressures of the PBP (APT300, Harvard Apparatus, Hollisten, MA, USA)
 3. Left ventricular volume (LVV) (Ventri-Cath 507 PV Loop Catheter/MPVS Ultra PV Unit, ADInstruments, 
Sydney, Australia)
 4. Arterial and venous oxygen partial pressures (PaO2, PvO2) as well as arterial and venous oxygen saturations 
(SaO2, SvO2) (CDI System 500, Terumo, Tokyo, Japan)
 5. Hemoglobin (Hb) (CDI System 500, Terumo, Tokyo, Japan).
The gain of the left ventricular volume conductance catheter was calibrated while the heart was unsupported 
by matching the measured cardiac output to the measured stroke volume multiplied by the heart rate. Offset 
(parallel conductance) of the ventricular volume catheter was calibrated after each experiment once cardiac activ-
ity had ceased completely. By inserting a latex balloon into the ventricle and gradually increasing the volume of 
fluid inside, the end-diastolic pressure volume relationship was determined.
oxygen consumption. The oxygen content in the arterial and venous systems (CaO2, CvO2 in ml O2/L) were cal-
culated from Hemoglobin (Hb in g/L), oxygen saturation (SO2 in %), and partial pressure of oxygen (PO2 in mmHg).
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The myocardial oxygen consumption (MVO2 in ml O2/min) was calculated from the coronary flow (Qcor in 
L/min) as:
MVO Q C O C O( ), (2)cor a v2 2 2= −
The energy consumption (P in J/beat) of the ventricle was calculated from the MVO2 and the heart rate (HR 
in beats/min), determined based on the LVP signal, as:
= ∗ .P MVO J
ml O
HR20 1 / ,
(3)2 2
Both EW and energy consumption were normalized for the heart weight and are presented in J/beat/100 g.
Delivered mechanical work. The mechanical work per beat of the ventricle was determined based on the 
recorded PV loops of the ventricle. The EW equals the area enclosed by PV loop for each cardiac cycle. It is the 
energy which is delivered to the vascular system by the left ventricle30.
Cardiac efficiency (in %) was defined as the ratio between the EW performed by the ventricle during each 
cardiac cycle and the total energy demand determined through the myocardial oxygen consumption (Eq. 3).
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